Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR(TM) MRD and InVisionFirst(R)-Lung Assays at the ESMO Congress 2021

FT MYERS, FL / ACCESSWIRE / September 9, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...

NEO : 46.26 (-1.45%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 182.71 (-1.95%)
OMCL : 148.66 (-3.21%)
AMN : 111.41 (-2.19%)
NEO : 46.26 (-1.45%)
XLV : 127.87 (-1.71%)
VHT : 249.22 (-1.99%)
NeoGenomics (NEO) Reports Q2 Loss, Tops Revenue Estimates

NeoGenomics (NEO) delivered earnings and revenue surprises of 80.00% and 1.02%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

NEO : 46.26 (-1.45%)
NeoGenomics Reports 40% Revenue Growth to $122 Million in the Second Quarter

NEO : 46.26 (-1.45%)
Earnings Preview: NeoGenomics (NEO) Q2 Earnings Expected to Decline

NeoGenomics (NEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NEO : 46.26 (-1.45%)
Bear of the Day: NeoGenomics (NEO)

Emerging diagnostics provider is steadily growing sales and key M&A but ran into an EPS cliff

NEO : 46.26 (-1.45%)
EXAS : 93.17 (-1.93%)
NVTA : 28.51 (-5.22%)
NTRA : 107.26 (-6.83%)
GH : 122.49 (-2.57%)
NeoGenomics Schedules its Second Quarter 2021 Earnings Release for August 6, 2021

FT. MYERS, FL / ACCESSWIRE / July 14, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to...

NEO : 46.26 (-1.45%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 182.71 (-1.95%)
OMCL : 148.66 (-3.21%)
AMN : 111.41 (-2.19%)
NEO : 46.26 (-1.45%)
XLV : 127.87 (-1.71%)
VHT : 249.22 (-1.99%)
NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

Acquisition establishes NeoGenomics as a technology leader in the minimal residual disease (MRD) testing market

NEO : 46.26 (-1.45%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 182.71 (-1.95%)
OMCL : 148.66 (-3.21%)
NEO : 46.26 (-1.45%)
XLV : 127.87 (-1.71%)
VHT : 249.22 (-1.99%)
ENSG : 75.42 (-1.96%)

Barchart Exclusives

Live Cattle: The Speedo Situation
Some of the chatter I'm hearing about the live cattle market reminded me of a story. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar